Health ❯ Healthcare ❯ Clinical Trials

Cancer Treatment

Head and Neck Cancer Colorectal Cancer Prostate Cancer Breast Cancer Multiple Myeloma CAR T-cell Therapy Combination Therapy PARP Inhibitors Immunotherapy Targeted Therapies

3 ARTICLES

4w ago

EMERALD-3 Trial Shows Progression-Free Survival Win for STRIDE Plus Lenvatinib With TACE

Investigators say the PFS benefit gives a rationale to test the STRIDE immunotherapy strategy earlier in treatment while overall survival continues to mature under follow-up.

4 ARTICLES

2mo ago

Erasca Shares Plunge After Trial Death and Patent Challenge

5 ARTICLES

2mo ago

Allogene Soars on Early ALPHA3 Readout Showing Strong MRD Edge and Clean Safety

3 ARTICLES

2mo ago

Transgene Completes Phase 2 Randomization for Personalized Cancer Vaccine TG4050

7 ARTICLES

3mo ago

Androgen Signaling Drives Lethal Pediatric Ependymoma, Study Finds

3 ARTICLES

3mo ago

Ligand-Based OSM CAR-T Shows Preclinical Efficacy Against Osteosarcoma

7 ARTICLES

5mo ago

ImmunityBio Sets 30-Day FDA Submission After Positive Meeting on Anktiva Expansion

3 ARTICLES

5mo ago

Abemaciclib Shows Early Benefit Signal in Genetically Selected High-Grade Meningioma Trial

3 ARTICLES

6mo ago

Acupuncture Improves Perceived Cognition With a Modest Memory Edge for Real Needling

3 ARTICLES

6mo ago

Exicure’s Burixafor Delivers About 90% Stem-Cell Mobilization in Phase 2 as Shares Surge

11 ARTICLES

6mo ago

Pirtobrutinib Extends First-Line PFS vs BR and Shows Higher Response Rates Than Ibrutinib in CLL/SLL

4 ARTICLES

6mo ago

Early Cilta-Cel Use Linked to Better Outcomes in Relapsed/Refractory Myeloma, ASH 2025 Data Show

3 ARTICLES

7mo ago

Early Cancer Gene Panel Testing Linked to Longer Survival in Kyoto Study

3 ARTICLES

8mo ago

Kisqali Cuts Recurrence in 5-Year NATALEE Results for High-Risk Early HR+/HER2- Breast Cancer

3 ARTICLES

8mo ago

One-Step CAR-NK Cells Evade Rejection and Nearly Clear Lymphoma in Mice

8 ARTICLES

8mo ago

Datroway Extends Survival Over Chemotherapy in First-Line TNBC Ineligible for Immunotherapy

6 ARTICLES

9mo ago

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

3 ARTICLES

9mo ago

TORPEdO Phase III Finds No One-Year Advantage for Proton Therapy Over IMRT in Oropharyngeal Cancer

3 ARTICLES

9mo ago

Glycan-Targeting ‘GlyTR’ Therapy Kills Diverse Cancers in Preclinical Tests

4 ARTICLES

9mo ago

Engineered Salmonella Triggers Tumor Immune Hubs, Slows Colorectal Cancer in Mice

Cancer Treatment

EMERALD-3 Trial Shows Progression-Free Survival Win for STRIDE Plus Lenvatinib With TACE

Erasca Shares Plunge After Trial Death and Patent Challenge

Allogene Soars on Early ALPHA3 Readout Showing Strong MRD Edge and Clean Safety

Transgene Completes Phase 2 Randomization for Personalized Cancer Vaccine TG4050

Androgen Signaling Drives Lethal Pediatric Ependymoma, Study Finds

Ligand-Based OSM CAR-T Shows Preclinical Efficacy Against Osteosarcoma

ImmunityBio Sets 30-Day FDA Submission After Positive Meeting on Anktiva Expansion

Abemaciclib Shows Early Benefit Signal in Genetically Selected High-Grade Meningioma Trial

Acupuncture Improves Perceived Cognition With a Modest Memory Edge for Real Needling

Exicure’s Burixafor Delivers About 90% Stem-Cell Mobilization in Phase 2 as Shares Surge

Never miss stories about

Cancer Treatment

Pirtobrutinib Extends First-Line PFS vs BR and Shows Higher Response Rates Than Ibrutinib in CLL/SLL

Early Cilta-Cel Use Linked to Better Outcomes in Relapsed/Refractory Myeloma, ASH 2025 Data Show

Early Cancer Gene Panel Testing Linked to Longer Survival in Kyoto Study

Kisqali Cuts Recurrence in 5-Year NATALEE Results for High-Risk Early HR+/HER2- Breast Cancer

One-Step CAR-NK Cells Evade Rejection and Nearly Clear Lymphoma in Mice

Datroway Extends Survival Over Chemotherapy in First-Line TNBC Ineligible for Immunotherapy

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

TORPEdO Phase III Finds No One-Year Advantage for Proton Therapy Over IMRT in Oropharyngeal Cancer

Glycan-Targeting ‘GlyTR’ Therapy Kills Diverse Cancers in Preclinical Tests

Engineered Salmonella Triggers Tumor Immune Hubs, Slows Colorectal Cancer in Mice

Never miss stories about

Cancer Treatment